Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months
Medicine (General)
0303 health sciences
COVID-19 Vaccines
Omicron
SARS-CoV-2
R
COVID-19
Articles
Live-virus neutralisation
3. Good health
Covishield
03 medical and health sciences
R5-920
Cross-Sectional Studies
Vaccines, Inactivated
ChAdOx1 nCoV-19
Covaxin
Medicine
Humans
DOI:
10.1016/j.ebiom.2022.103938
Publication Date:
2022-03-16T04:15:14Z
AUTHORS (21)
ABSTRACT
Rapid spread of the omicron SARS-CoV-2 variant despite extensive vaccination suggests immune escape. The neutralising ability different vaccines alone or with natural infection against is not well-known.In this cross-sectional study, we tested vaccine and induced antibodies to neutralise in a live virus neutralisation assay four groups individuals: (i) ChAdOx1 nCoV-19 vaccination, (ii) plus prior infection, (iii) inactivated (BBV152), (iv) BBV152 infection. Primary outcome was fold-change titre compared ancestral virus.We included 80 subjects. geometric mean (GMT) 50% focus reduction test (FRNT50) 380·4 (95% CI: 221·1, 654·7) 379·3 185·6, 775·2) nCov-19 alone. GMT for were 806·1 478·5, 1357·8) 1526·2 853·2, 2730·0), respectively. Against variant, only 5 out 20 both groups, 6 group, 9 group exhibited titres above lower limit quantification (1:20) suggesting better A 26·6 25·7 fold FRNT50 Omicron strain observed individuals without vaccinated nCoV-19, corresponding 57·1 58·1 fold, respectively, demonstrated moderate correlation serum anti-RBD IgG levels [Spearman r: 0·58 (0·41, 0·71)].Significant vaccine-induced infection-induced which might explain escape.Department Biotechnology, India; Bill & Melinda Gates Foundation, USA.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (49)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....